$BPTH is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease.
They release today the news of a US patent for their technology.
Here is the link of the news.
I saved the graph of the day here.
Here is the 30 day graph.